Abstract | OBJECTIVE: STUDY DESIGN: Open prospective study. PATIENTS: A CECI was performed in 29 patients suffering for more than 12 months from a non-compressive and non-surgical CCBN with permanent pain for at least three months non relieved by an adequately conducted medical treatment. METHODS: The cervical epidural space was injected (C7-T1, 18 G needle) with an increasing volume (maximum 10 mL) of isotonic saline solution to exacerbate patient's cervicobrachial pain. The patients then received an equivalent volume of 0.5% lidocaine plus triamcinolone acetonide (10 mg.mL-1). The pain decrease was estimated on a visual analogic scale (VAS), in comparison to intensity of pain rated at 100 mm before CECI. RESULTS: The mean volume injected into the epidural space was 6 +/- 2 mL. It increased pain in 26 out of 29 patients. After 3 months, a success rate of 83% was obtained, with a pain rate of 12 mm on VAS. Concerning mid- and long-term results, pain relief remained stable for at least 24 months (mean follow-up: 48 +/- 18 months). Simultaneously, the need for analgesics decreased significantly. CONCLUSION: A single CECI in patients suffering from non-compressive and non-surgical CCBN results in long-lasting pain relief.
|
Authors | B Grenier, L Castagnera, P Maurette, P Erny, J Senegas |
Journal | Annales francaises d'anesthesie et de reanimation
(Ann Fr Anesth Reanim)
Vol. 14
Issue 6
Pg. 484-8
( 1995)
ISSN: 0750-7658 [Print] France |
Vernacular Title | Névralgie cervico-brachiale chronique traitée par injection péridurale cervicale de corticoïdes. Résultats à long terme. |
PMID | 8745972
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Anti-Inflammatory Agents
- Glucocorticoids
- Triamcinolone Acetonide
|
Topics |
- Administration, Topical
- Adult
- Anti-Inflammatory Agents
(administration & dosage, therapeutic use)
- Brachial Plexus Neuritis
(drug therapy)
- Cervical Vertebrae
- Chronic Disease
- Female
- Glucocorticoids
- Humans
- Injections, Epidural
- Male
- Middle Aged
- Pain Measurement
- Prospective Studies
- Treatment Outcome
- Triamcinolone Acetonide
(administration & dosage, therapeutic use)
|